Delivery Order SPE2DB22D1106-SPE2DB25FDTU5

Award Date 1/10/25
Potential Completion Date 1/13/25
Potential Value $3.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $21,102.07 and runs through February 10, 2025. It is for the delivery of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a medical product used in healthcare settings. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $6,727.55, is for the delivery of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a medical product, and has an ultimate completion date of February 27, 2025. The contract is a Delivery Order under a Firm Fixed Price type. This award is not designated with a set-aside and appears to be part of a larger Indefinite...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,459.59, is for the delivery of EUFLEXXA 20 MG/2 ML SYRINGE 2ML, a medical product, to support military healthcare programs. The contract has an ultimate completion date of February 21, 2024 and was awarded on February 20, 2024. This delivery order is part of a larger...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the procurement of EUFLEXXA 20 MG/2 ML SYRINGE 2ML medical supplies. The contract is a Delivery Order with a Firm Fixed Price type and a ceiling value of $5,010.99. It has an ultimate completion date of September 20, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,740.21, is for the delivery of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $11,072.14 and is for the delivery of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a medical product. The contract has a period of performance that runs through February 25, 2025. The contract is a Firm Fixed Price type and does not have a set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,987.28 contract is for the delivery of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a medical product used in the treatment of various medical conditions. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 31, 2024. Amerisourcebergen holds a significant...
This is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $7,671.35, is for the supply of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a medical product used in healthcare. This contract is not designated as a set-aside. The contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,747.31, is for the delivery of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML medical supplies. The contract has a completion date of July 3, 2024 and is a firm fixed-price delivery order. The award was made on July 2, 2024 and does not have a set-aside designation, indicating open competition....
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,420.08 Firm Fixed Price Delivery Order is for the supply of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a pharmaceutical product, with an ultimate completion date of October 30, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FDTU5
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,179.64, is for the supply of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML medical products. The contract has an ultimate completion date of January 13, 2025 and is a firm fixed-price contract. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 4/11/25, 11:23 AM